Search Trials
Conditions
Learn
About

This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

Clinical Utility of LIBS Multi-Element Imaging and the IFF Algorithm in Chronic Lung Diseases | MicrobiomeTrials

← Back to trials

NCT07597187

Clinical Utility of LIBS Multi-Element Imaging and the IFF Algorithm in Chronic Lung Diseases

RecruitingOBSERVATIONAL

Trial Details

Start: 2026-10-01Est. Completion: 2027-06-01

Enrollment target: 70 participants

Locations

CHU Grenoble Alpes, Grenoble, France
Centre Hospitalier Régional Universitaire Nancy (CHRU), Nancy, France
centre Hospitalier Universitaire Rouen (CHU), Rouen, France

Contact

Benoit BUSSERBBusser@chu-grenoble.fr +33476768939

Vincent BONNETERREVBonneterre@chu-grenoble.fr +33476765851

Other microbiome trials you might be interested in

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell HistiocytosisPhase 2Recruiting

Recurrent Langerhans Cell HistiocytosisRefractory Langerhans Cell Histiocytosis

This phase II trial tests the safety, side effects, best dose and activity of tovorafenib (DAY101) in treating patients …

Birmingham, United StatesEst. completion Sep 30, 2028

View Trial →

Fibrotic Disease Activity in Cardiopulmonary Disorders Using 18F-Fibroblast Activation Protein Inhibitor (18F-FAPI-74) PET/CT ImagingPhase 3Recruiting

Allogeneic Stem Cell TransplantationLung Allograft TransplantationInterstitial Lung DiseaseAcute Lung InjuryPulmonary Arterial HypertensionCardiovascular Diseases

Background: Injury or diseases of the heart and lung can sometimes cause scar tissue (fibrosis) to build up in those or…

Bethesda, United StatesEst. completion May 26, 2031

View Trial →

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.